R1 RCM, Health Catalyst Downgraded as KeyBanc Reviews Health-tech Space
Seeking AlphaApr 10 12:56 ET
Truist Financial Reaffirms Their Buy Rating on Phreesia (PHR)
TipRanksApr 9 07:36 ET
Piper Sandler Sticks to Their Buy Rating for Phreesia (PHR)
TipRanksApr 5 06:47 ET
Analysts Offer Insights on Healthcare Companies: ProSomnus (OSA), Merck & Company (MRK) and Phreesia (PHR)
TipRanksMar 27 08:30 ET
Phreesia Analyst Ratings
BenzingaMar 22 12:54 ET
Phreesia Analyst Ratings
BenzingaMar 21 10:16 ET
Analysts Offer Insights on Healthcare Companies: Phreesia (PHR) and OmniAb (OABI)
TipRanksMar 21 07:10 ET
Phreesia (PHR) Gets a Buy From JMP Securities
TipRanksMar 21 03:45 ET
Raymond James Raises Phreesia's Price Target to $30 From $25, Maintains Outperform Rating
MT NewswiresMar 15 12:28 ET
D.A. Davidson Remains a Buy on Phreesia (PHR)
TipRanksMar 15 08:36 ET
Phreesia Analyst Ratings
BenzingaMar 15 08:21 ET
RBC Raises Price Target on Phreesia to $23 From $17, Cites 'Encouraging Progress Toward Profitability,' Keeps Sector Perform Rating
MT NewswiresMar 15 07:39 ET
Phreesia's Financial Resilience and Strategic Growth Positioning Warrant a Buy Rating
TipRanksMar 15 07:16 ET
RBC Capital Reaffirms Their Hold Rating on Phreesia (PHR)
TipRanksMar 15 06:46 ET
Phreesia: A Buy Rating With Profitable Growth and Strong FY25 Outlook
TipRanksMar 15 05:16 ET
Analysts Offer Insights on Healthcare Companies: Fortress Biotech (FBIO) and Phreesia (PHR)
TipRanksMar 15 04:50 ET
KeyBanc Sticks to Their Buy Rating for Phreesia (PHR)
TipRanksMar 13 03:55 ET
Phreesia Analyst Ratings
BenzingaMar 12 10:10 ET
Truist Financial Sticks to Its Buy Rating for Phreesia (PHR)
TipRanksMar 12 08:38 ET
Phreesia (PHR) Receives a Buy From JMP Securities
TipRanksMar 12 00:55 ET
No Data
No Data